GlassScriptPhysician profile
Ty Brown
NPI 1205037470
$6,586.85
in general payments reported to CMS, 2019-2025
41 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $398 · 2021: $838 · 2022: $644 · 2023: $1,427 · 2024: $1,525 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,571 · Education: $65.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,571.19 |
| Education | $65.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $1,272.38 | 2019-2025 | Crexont, Rytary, Ongentys |
| Sk Life Science, INC. | $824.68 | 2021-2025 | Xcopri |
| Ceribell, INC. | $703.03 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Abbvie INC. | $578.74 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Acadia Pharmaceuticals INC | $362.00 | 2021-2023 | Nuplazid |
| Jazz Pharmaceuticals INC. | $348.11 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $329.56 | 2019-2020 | |
| Genzyme Corporation | $254.89 | 2019-2021 | |
| Biogen, INC. | $244.91 | 2019-2024 | Tysabri, Vumerity |
| Sunovion Pharmaceuticals INC. | $185.63 | 2019 | |
| Ucb, INC. | $143.77 | 2019-2025 | Zilbrysq, Fintepla |
| Biohaven Pharmaceutical Holding Company LTD. | $134.86 | 2022 | |
| Lilly USA, LLC | $111.95 | 2020-2025 | Kisunla, Amyvid |
| Novartis Pharmaceuticals Corporation | $106.34 | 2019-2023 | |
| Eisai INC. | $103.00 | 2019-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ty Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.